Literature DB >> 2111548

Binding and biological effects of tumor necrosis factor and gamma interferon in human pancreatic carcinoma cells.

A B Raitano1, P Scuderi, M Korc.   

Abstract

The cytotoxic/cytostatic effects of recombinant human tumor necrosis factor alpha (rhTNF) and gamma interferon (rhIFN-gamma) were studied in five human pancreatic tumor cell lines. During a 48-h incubation, MIA PaCa-2 cells were most sensitive to rhTNF (56% cytotoxicity, 500 U/ml), T3M4 cells were most sensitive to rhIFN-gamma (54% cytostasis, 250 U/ml), and ASPC-1 and COLO 357 cells were most sensitive to the combination of rhTNF and rhIFN-gamma (56 and 55% cytotoxicity, respectively, 250 U/ml of each cytokine). The PANC-1 cells were relatively insensitive to either the individual or the combined effects of these cytokines. All five cell lines exhibited specific, high-affinity receptors for 125I-labeled rhTNF (480-8,610 sites/cell) and rhIFN-gamma (2,050-6,280 sites/cell). The MIA PaCa-2 cells, which were the most sensitive to the inhibitory effects of rhTNF, also possessed the largest number of 125I rhTNF receptors; all other cell lines had a relatively low number of binding sites and low sensitivity. In contrast, no direct correlation could be made between the number of IFN-gamma binding sites and inhibitory sensitivity in any of the cell lines. Incubation of COLO 357 cells at 37 degrees C with either 125I rhTNF or 125I rhINF-gamma led to internalization of the respective 125I-labeled ligand. Our findings document the presence of cytokine receptors in human pancreatic carcinoma cells and suggest that postreceptor events rather than differences in receptor number or affinity more likely govern the responsiveness of pancreatic cancer cells to TNF and IFN-gamma.

Entities:  

Mesh:

Substances:

Year:  1990        PMID: 2111548     DOI: 10.1097/00006676-199005000-00005

Source DB:  PubMed          Journal:  Pancreas        ISSN: 0885-3177            Impact factor:   3.327


  8 in total

1.  RNA interference demonstrates a novel role for integrin-linked kinase as a determinant of pancreatic adenocarcinoma cell gemcitabine chemoresistance.

Authors:  Mark S Duxbury; Hiromichi Ito; Eric Benoit; Talat Waseem; Stanley W Ashley; Edward E Whang
Journal:  Clin Cancer Res       Date:  2005-05-01       Impact factor: 12.531

2.  Long-term effect of tumor necrosis factor and gamma interferon in human pancreatic carcinoma cells.

Authors:  A B Raitano; P Scuderi; M Korc
Journal:  Int J Pancreatol       Date:  1990-03

3.  Interferon γ improves the vaccination potential of oncolytic parvovirus H-1PV for the treatment of peritoneal carcinomatosis in pancreatic cancer.

Authors:  Svitlana P Grekova; Marc Aprahamian; Laurent Daeffler; Barbara Leuchs; Assia Angelova; Thomas Giese; Angel Galabov; Anette Heller; Nathalia A Giese; Jean Rommelaere; Zahari Raykov
Journal:  Cancer Biol Ther       Date:  2011-11-15       Impact factor: 4.742

4.  Differentiation of pancreatic ductal carcinoma cells associated with selective expression of protein kinase C isoforms.

Authors:  M G Franz; J G Norman; P J Fabri; W R Gower
Journal:  Ann Surg Oncol       Date:  1996-11       Impact factor: 5.344

5.  Homo sapiens systemic RNA interference-defective-1 transmembrane family member 1 (SIDT1) protein mediates contact-dependent small RNA transfer and microRNA-21-driven chemoresistance.

Authors:  Mohamed O Elhassan; Jennifer Christie; Mark S Duxbury
Journal:  J Biol Chem       Date:  2011-12-15       Impact factor: 5.157

6.  Antidiabetic thiazolidinediones induce ductal differentiation but not apoptosis in pancreatic cancer cells.

Authors:  Elisabetta Ceni; Tommaso Mello; Mirko Tarocchi; David-W Crabb; Anna Caldini; Pietro Invernizzi; Calogero Surrenti; Stefano Milani; Andrea Galli
Journal:  World J Gastroenterol       Date:  2005-02-28       Impact factor: 5.742

7.  Systemic siRNA-mediated gene silencing: a new approach to targeted therapy of cancer.

Authors:  Mark S Duxbury; Evan Matros; Hiromichi Ito; Michael J Zinner; Stanley W Ashley; Edward E Whang
Journal:  Ann Surg       Date:  2004-10       Impact factor: 12.969

8.  A variant epidermal growth factor receptor exhibits altered type alpha transforming growth factor binding and transmembrane signaling.

Authors:  T Moriai; M S Kobrin; C Hope; L Speck; M Korc
Journal:  Proc Natl Acad Sci U S A       Date:  1994-10-11       Impact factor: 11.205

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.